Stable Non-Clonal Cell Pools for First-in-Human Biologics
Experience.
History-Making.
3 Predictions for BPI East 2026: The Industry Is Entering a New Era of Biomanufacturing
GBI Biomanufacturing to Launch SmartScale™ GMP Solutions at BioProcess International East 2026
ATF vs TFF Perfusion: Which Cell-Retention Method Fits Your Bioprocess?
GBI Bio Appoints Jesse McCool, Ph.D., as Chief Executive Officer
Antibody–Oligonucleotide Conjugates Clinical Manufacturing — A New Paradigm Shift of Bio-Conjugates for Therapeutics
BIO International 2026: Twenty Years After FDA’s Exploratory IND Guidance: Is the Time Finally Right for Exploratory Development of Therapeutic Antibodies and Recombinant Proteins?
What’s the Buzz?! Episode Recording
What’s the Buzz?! | BioFlorida and the Regenerative Medicine Bloom
